AU2013257707A1 - Compositions and methods for the treatment of epilepsy - Google Patents
Compositions and methods for the treatment of epilepsy Download PDFInfo
- Publication number
- AU2013257707A1 AU2013257707A1 AU2013257707A AU2013257707A AU2013257707A1 AU 2013257707 A1 AU2013257707 A1 AU 2013257707A1 AU 2013257707 A AU2013257707 A AU 2013257707A AU 2013257707 A AU2013257707 A AU 2013257707A AU 2013257707 A1 AU2013257707 A1 AU 2013257707A1
- Authority
- AU
- Australia
- Prior art keywords
- disorder
- administration
- formula
- compositions
- seizures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1791/CHE/2012 | 2012-05-08 | ||
IN1791CH2012 | 2012-05-08 | ||
PCT/IB2013/050740 WO2013167986A2 (fr) | 2012-05-08 | 2013-01-29 | Compositions et méthodes de traitement de l'épilepsie |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2013257707A1 true AU2013257707A1 (en) | 2014-11-27 |
Family
ID=54187089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2013257707A Abandoned AU2013257707A1 (en) | 2012-05-08 | 2013-01-29 | Compositions and methods for the treatment of epilepsy |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2846795A2 (fr) |
JP (1) | JP2015526385A (fr) |
AU (1) | AU2013257707A1 (fr) |
CA (1) | CA2873016A1 (fr) |
SG (1) | SG11201407309XA (fr) |
WO (1) | WO2013167986A2 (fr) |
ZA (1) | ZA201408058B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2873094A1 (fr) * | 2012-05-07 | 2013-11-14 | Cellixbio Private Limited | Promedicaments d'agents antiplaquettaires |
SG11201407328TA (en) * | 2012-07-03 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of moderate to severe pain |
CA2950788C (fr) | 2014-06-02 | 2022-10-04 | Ketogen Inc. | Composes pour le traitement de crises epileptiques et d'autres troubles et affections du systeme nerveux central |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9708394A (es) * | 1995-05-05 | 1998-02-28 | Novo Nordisk As | Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion. |
WO2006062980A2 (fr) * | 2004-12-07 | 2006-06-15 | Nektar Therapeutics | Formulation non cristalline stable comprenant de la tiagabine |
US8338621B2 (en) * | 2005-12-21 | 2012-12-25 | Ucb S.A. | Process for the preparation of 2-oxo-1-pyrrolidine derivatives |
WO2010132693A2 (fr) * | 2009-05-13 | 2010-11-18 | Nektar Therapeutics | Composés pyrrolidine contenant un oligomère |
-
2013
- 2013-01-29 AU AU2013257707A patent/AU2013257707A1/en not_active Abandoned
- 2013-01-29 JP JP2015510893A patent/JP2015526385A/ja active Pending
- 2013-01-29 EP EP13787779.1A patent/EP2846795A2/fr not_active Withdrawn
- 2013-01-29 WO PCT/IB2013/050740 patent/WO2013167986A2/fr active Application Filing
- 2013-01-29 SG SG11201407309XA patent/SG11201407309XA/en unknown
- 2013-01-29 CA CA2873016A patent/CA2873016A1/fr not_active Abandoned
-
2014
- 2014-11-04 ZA ZA2014/08058A patent/ZA201408058B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2846795A2 (fr) | 2015-03-18 |
CA2873016A1 (fr) | 2013-11-14 |
WO2013167986A2 (fr) | 2013-11-14 |
SG11201407309XA (en) | 2014-12-30 |
ZA201408058B (en) | 2016-03-30 |
WO2013167986A3 (fr) | 2015-06-18 |
JP2015526385A (ja) | 2015-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9499527B2 (en) | Compositions and methods for the treatment of familial amyloid polyneuropathy | |
AU2013257717A1 (en) | Compositions and methods for the treatment of metabolic syndrome | |
WO2014087367A2 (fr) | Compositions et procédés pour le traitement de maladies neurologiques et de leurs complications associées | |
WO2014068463A2 (fr) | Compositions et procédés de traitement d'une inflammation et de troubles métaboliques | |
US9738631B2 (en) | Compositions and methods for the treatment of neurological disorders | |
AU2013257707A1 (en) | Compositions and methods for the treatment of epilepsy | |
WO2015033279A1 (fr) | Compositions et méthodes pour le traitement de l'homocystinurie | |
US20150141500A1 (en) | Compositions and methods for the treatment of neurological diseases | |
WO2014097137A2 (fr) | Compositions et méthodes destinées à traiter les avc et autres maladies neurologiques | |
WO2014195850A2 (fr) | Compositions et méthodes de traitement de maladies neurologiques et de troubles neurologiques | |
WO2014068506A2 (fr) | Compositions et procédés pour le traitement de maladies autoimmunes | |
AU2013257710A1 (en) | Compositions and methods for the treatment of neurological disorders | |
US9242939B2 (en) | Compositions and methods for the treatment of respiratory disorders | |
CA2873094A1 (fr) | Promedicaments d'agents antiplaquettaires | |
WO2014068459A2 (fr) | Compositions et méthodes de traitement de la douleur et de maladies neurologiques | |
WO2014057439A2 (fr) | Compositions et procédés de traitement de maladies neurologiques et des complications associées | |
WO2014068461A2 (fr) | Compositions et méthodes de traitement d'une inflammation aiguë | |
US9290486B1 (en) | Compositions and methods for the treatment of epilepsy | |
US9187427B2 (en) | N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases | |
WO2013179153A1 (fr) | Compositions et méthodes de traitement de troubles neurologiques dégénératifs et de maladies neurologiques | |
US9303038B2 (en) | Compositions and methods for the treatment of epilepsy and neurological diseases | |
AU2013311349A1 (en) | Compositions and methods for treatment of inflammation and lipid disorders | |
US9266823B2 (en) | Compositions and methods for the treatment of parkinson's disease | |
WO2014122575A2 (fr) | Conjugués d'acide gras pour le traitement d'inflammations et de maladies métaboliques | |
WO2013167999A2 (fr) | Compositions et méthodes de traitement d'affections neurologiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |